Cardiac Myosin Light Chain II in Conscious Dogs" (Circ Res 1989;65:684-694) The September 1989 issue of Circulation Research contained an interesting study by Dr Figure  5 of the study by Isobe et al, reperfusion causes a significant shortening of the release phase and thus will produce higher values of Kd. Indeed, Table 1 quotes mean values of 0.00129 minute-', 0.00154 minute-', and 0.00109 minute`for the 3-hour reperfusion, the 6-hour reperfusion, and the permanent occlusion groups, respectively. If instead of these values a fixed value of Kd=0.0048 minute`was used, as in the original Shell method,3 the ratios of CK release/infarct size would have been (0.0048/ 0.00129)x579=2,154, (0.0048/0.00154)x574=1,789, and (0.0048/ 0.00109)x381=1,678 IU .l-g-', respectively, and these differences are clearly not significant in view of the standard errors of about 30%.
The September 1989 issue of Circulation Research contained an interesting study by Dr. M. Isobe et al. In this study the release in plasma of creatine kinase (CK) after coronary occlusion in the dog is compared with histologically assessed infarct size. It is suggested that, in the setting of reperfusion, myosin light chain II is a better indicator of infarct size than CK because reperfusion causes more release of CK per gram of infarcted tissue than observed after permanent coronary occlusion. From Table 1 it follows that the ratio of total CK release/infarct size is 579, 574, and 381 IU -11 g-1 for reperfusion after 3 hours, reperfusion after 6 hours, and permanent occlusion, respectively. These figures indeed suggest enhanced CK release after reperfusion.
However In this respect, Figure 7 is also somewhat misleading because, owing to a single outlying value, linear regression of CK release versus infarct size produced a slope of 175 in the permanent occlusion group, instead of the mean value of 381 from Table 1 .
In conclusion, the data presented in this study do not support the conclusion that CK is subject to reperfusion-induced enhancement of the ratio of CK release/infarct size. To Results from Dr. Hermens' laboratory3 on plasma clearance of injected CK in eight dogs showed that the clearance constant ranged from 0.27 to 0.47/hr (0.36±0.030, mean±SEM), as did results from another laboratory4 (from 0.0039 to 0.0091/ min). Thus, errors in estimating the total release of CK from a constant Kd value are by no means insignificant. Furthermore, the methods for estimating the constant Kd value also call for some consideration. Kd values have been reported for normal animals3,4 and for animals with coronary occlusion without reperfusion5 by intravenous injection of partially purified exogenous CK. As is obvious from our Figure 7 and from another report,6 reperfusion significantly increases the entry ratio of CK from infarcted myocardium into the circulation. Changes in the entry ratio might alter the clearance of the enzyme from the circulation. Therefore, another experiment would be necessary to establish whether a Kd value estimated for normal animals or animals with nonreperfused infarction is valid for animals with early reperfusion.
It is also uncertain whether early coronary reperfusion influ- 
